Methadone Maintenance for Prisoners
Information source: Friends Research Institute, Inc.
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Heroin Addiction
Intervention: Counseling Only (Other); Counseling + Transfer (Drug); Counseling + Methadone (Drug)
Phase: Phase 3
Status: Completed
Sponsored by: Friends Research Institute, Inc. Official(s) and/or principal investigator(s): Timothy W Kinlock, Ph.D., Principal Investigator, Affiliation: Friends Research Institute, Inc.
Summary
This five-year study examines the benefits of methadone maintenance treatment initiated in
prison and continued in the community to male offenders who were previously, but not
currently, heroin-dependent. It is anticipated that such prisoners will have more favorable
outcomes in the year following release with regard to drug abuse, crime, and HIV risk
behavior than either prisoners who receive counseling only or begin initiation of methadone
maintenance in the community
Clinical Details
Official title: Methadone Maintenance for Prisoners
Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcome: Treatment Retention in the CommunityHeroin Use Cocaine Use HIV-risk Behaviors Criminal Activity
Secondary outcome: Employment
Detailed description:
Most prisoners with histories of pre-incarceration heroin addiction do not receive treatment
while incarcerated or upon release. Effective treatment for such prisoners is urgently
needed because rapid relapse typically follows release. Relapse is associated with increased
risk for HIV, overdose death, criminal activity, and reincarceration. Other than three
studies of methadone maintenance with short-term jail inmates, the only study of longer-term
inmates who were previously, but not currently, heroin-dependent was the investigator's
pilot study with pre-release inmates. Based on that pilot study, which found that initiating
maintenance treatment is feasible and facilitates post-release treatment entry, the present
study provides a more rigorous examination of this unique treatment approach.
Eligibility
Minimum age: 18 Years.
Maximum age: 65 Years.
Gender(s): Male.
Criteria:
Inclusion Criteria:
- Heroin dependence in the year prior to current incarceration
- 3-6 months left to serve in prison-male pre-release inmate suitability for methadone
maintenance as determined by medical evaluation
- Willingness to enroll in methadone maintenance
- Having a Baltimore address
Exclusion Criteria:
- Pending parole hearing
- Pending charges
- Kidney failure
- Liver failure
Locations and Contacts
Metropolitan Transition Center, Baltimore, Maryland 21201, United States
Additional Information
Related publications: Kinlock TW, Schwartz RP, Gordon MS. The significance of interagency collaboration in developing opioid agonist programs for inmates. Corrections Compendium 30(3)6-9,28-30,2005.
Starting date: September 2003
Last updated: April 1, 2014
|